Key Points Revenue grew 23% year over year (GAAP) in Q2 2025, but missed analyst estimates by $4.1 million (GAAP). The telehealth segment achieved 30.0% revenue growth, with Adjusted EBITDA rising 560 ...

Revenue (GAAP) grew 4.5% to $297.1 million in Q2 2025 compared to the prior-year period. Cash flows from operating activities (GAAP) fell sharply to $9.1 million, reflecting lingering impacts of a ...

Patient Capital Management highlights Q2 winners like QXO and Nvidia, while exiting NFE over default risks. See what’s ...

Snap’s Q2 results showcased decelerating revenue growth, declining U.S. users, and rising infrastructure costs. Read why SNAP stock is a Sell.

Q2 2025 Management View Jason Potter, President and CEO, reported, "We delivered solid second quarter results that exceeded our outlook. Net sales of $1.18 billion grew 4.5% over last year, while ...

Suncor Energy delivered record upstream and downstream production in Q2 2025, offsetting lower commodity prices with strong ...

Q2 2025 Management View Frank D. Lee, CEO, reported progress across corporate, clinical, and commercial initiatives, stating, ...